Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Accumulated Expenses: 2020-2024

Historic Accumulated Expenses for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $1.2 million.

  • iSpecimen's Accumulated Expenses fell 29.88% to $716,878 in Q3 2025 from the same period last year, while for Sep 2025 it was $716,878, marking a year-over-year decrease of 29.88%. This contributed to the annual value of $1.2 million for FY2024, which is 24.13% down from last year.
  • As of FY2024, iSpecimen's Accumulated Expenses stood at $1.2 million, which was down 24.13% from $1.5 million recorded in FY2023.
  • iSpecimen's Accumulated Expenses' 5-year high stood at $3.7 million during FY2020, with a 5-year trough of $1.0 million in FY2021.
  • For the 3-year period, iSpecimen's Accumulated Expenses averaged around $1.4 million, with its median value being $1.5 million (2022).
  • In the last 5 years, iSpecimen's Accumulated Expenses crashed by 72.69% in 2021 and then spiked by 51.64% in 2022.
  • Over the past 5 years, iSpecimen's Accumulated Expenses (Yearly) stood at $3.7 million in 2020, then tumbled by 72.69% to $1.0 million in 2021, then soared by 51.64% to $1.5 million in 2022, then grew by 0.61% to $1.5 million in 2023, then fell by 24.13% to $1.2 million in 2024.